Cannvas to Begin Trading on the Canadian Securities Exchange Bringing Advanced Technology to Cannabis Health Sciences
TORONTO, June 29, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC), a leading business technology company within the cannabis health sciences space, is pleased to announce that the Canadian Securities Exchange (the “CSE”) has conditionally approved the Company’s application to list its common shares. The Company expects that its common shares will commence trading on the CSE under the ticker symbol “MTEC”, effective 9:30 am EST on Tuesday, July 3, 2018.
Based in Toronto, Cannvas operates in the cannabis health sciences space. The Company is currently designing and building customer solutions that are intended to enable those utilizing the Company’s educational platform to harness the power of data and be better able to understand the entirety of the industry.
“The listing for Cannvas on the CSE represents the culmination of considerable hard work and effort by an exceptional and dedicated team who believe in the significant potential of our company and our technology,” said Shawn Moniz, chief executive officer of Cannvas. “Medical cannabis has emerged to become an important economic and healthcare issue with a significant potential to improve the health and wellness of patients worldwide. Our first offering is a scalable, patient-centric life sciences learning platform for the cannabis space. From patients and consumers to medical practitioners and licensed producers, our platform will allow for global interaction and define the future face of cannabis education. By listing on the CSE, we hope to gain access to capital to grow our business and continue our journey toward becoming a leading business technology company within the cannabis space.”
Cannvas evolved from a need and ability to use technology and data to disrupt the status quo. With the world as a canvas, the Company seeks to harness the power of data and design to build customer-centric initiatives in the medical technology sector that provide better outcomes for all stakeholders. Cannvas is made up of four connected divisions offering design and execution expertise across advanced technology, data, blockchain, and creative disciplines.
The CSE was recognized as a stock exchange in 2004 and operates to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. For more information visit: www.thecse.ca.
About Cannvas MedTech Inc.
Cannvas MedTech Inc. is a leading business technology company within the cannabis health sciences space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: www.cannvasmedtech.com, Media Inquiries, firstname.lastname@example.org; Investor Relations, email@example.com, 1-800-489-0116